Jinbiao Zhan

749 total citations
29 papers, 541 citations indexed

About

Jinbiao Zhan is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jinbiao Zhan has authored 29 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Immunology and 10 papers in Oncology. Recurrent topics in Jinbiao Zhan's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Toxin Mechanisms and Immunotoxins (8 papers) and Transgenic Plants and Applications (6 papers). Jinbiao Zhan is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Toxin Mechanisms and Immunotoxins (8 papers) and Transgenic Plants and Applications (6 papers). Jinbiao Zhan collaborates with scholars based in China, United States and Hong Kong. Jinbiao Zhan's co-authors include Keying Liang, Qian Ding, Shenghao Wang, Shuqing Chen, Saif Ullah, Jie Chen, Muhammad Saleem Iqbal Khan, Mingo M. H. Yung, Xuan Yang and Keyi Wang and has published in prestigious journals such as Biomaterials, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Jinbiao Zhan

29 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinbiao Zhan China 13 258 170 140 109 69 29 541
Aizhi Zhao China 13 297 1.2× 196 1.2× 166 1.2× 196 1.8× 103 1.5× 23 633
Lai Sum Leoh United States 11 267 1.0× 103 0.6× 61 0.4× 83 0.8× 89 1.3× 14 519
Mylène A. Carrascal Portugal 15 446 1.7× 179 1.1× 76 0.5× 351 3.2× 40 0.6× 29 756
Sangeeta Bafna United States 10 636 2.5× 290 1.7× 132 0.9× 206 1.9× 127 1.8× 12 896
Uli Binder Germany 10 345 1.3× 92 0.5× 190 1.4× 126 1.2× 36 0.5× 12 564
Ida H. van der Meulen‐Muileman Netherlands 14 291 1.1× 110 0.6× 66 0.5× 33 0.3× 34 0.5× 21 460
Debra L. Wood United States 17 401 1.6× 244 1.4× 76 0.5× 175 1.6× 178 2.6× 32 846
Salam Kadhim Canada 11 232 0.9× 194 1.1× 24 0.2× 107 1.0× 62 0.9× 21 601
Hyunbo Shim South Korea 17 439 1.7× 174 1.0× 310 2.2× 173 1.6× 30 0.4× 42 762

Countries citing papers authored by Jinbiao Zhan

Since Specialization
Citations

This map shows the geographic impact of Jinbiao Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinbiao Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinbiao Zhan more than expected).

Fields of papers citing papers by Jinbiao Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinbiao Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinbiao Zhan. The network helps show where Jinbiao Zhan may publish in the future.

Co-authorship network of co-authors of Jinbiao Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Jinbiao Zhan. A scholar is included among the top collaborators of Jinbiao Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinbiao Zhan. Jinbiao Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ali, Hamid, et al.. (2022). Bioengineering and computational analysis of programmed cell death ligand-1 monoclonal antibody. Frontiers in Immunology. 13. 1012499–1012499. 3 indexed citations
2.
Liang, Keying, et al.. (2021). Expression and functional identification of recombinant SARS-CoV-2 receptor binding domain (RBD) from E. coli system. Preparative Biochemistry & Biotechnology. 52(3). 318–324. 14 indexed citations
3.
Liang, Keying, et al.. (2021). Dynamics of Endocytosis and Degradation of Antibody-Drug Conjugate T-DM1 in HER2 Positive Cancer Cells. Drug Design Development and Therapy. Volume 15. 5135–5150. 20 indexed citations
4.
Chan, David W., Mingo M. H. Yung, Yau-Sang Chan, et al.. (2020). MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis. Pharmacological Research. 161. 105157–105157. 97 indexed citations
5.
Wang, Shenghao, et al.. (2018). Polyclonal antibody production against rGPC3 and their application in diagnosis of hepatocellular carcinoma. Preparative Biochemistry & Biotechnology. 48(5). 435–445. 4 indexed citations
6.
Chen, Jie, Shenghao Wang, Saif Ullah, et al.. (2017). Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates. Drug Design Development and Therapy. Volume 11. 2265–2276. 112 indexed citations
7.
Chen, Jie, Shenghao Wang, Saif Ullah, et al.. (2017). Construction of high level prokaryotic expression and purification system of PD-L1 extracellular domain by using Escherichia coli host cell machinery. Immunology Letters. 190. 34–41. 15 indexed citations
8.
9.
Wang, Shuang, Meiping Ding, Dengchang Wu, Jinbiao Zhan, & Zhong Chen. (2007). ω-Conotoxin MVIIA inhibits amygdaloid kindled seizures in Sprague–Dawley rats. Neuroscience Letters. 413(2). 163–167. 4 indexed citations
10.
11.
Wang, Feng, et al.. (2006). Recombinant ??-Conotoxin MVIIA Possesses Strong Analgesic Activity. BioDrugs. 20(5). 275–281. 16 indexed citations
12.
Zhan, Jinbiao, et al.. (2006). Identification of peptide mimetics of xenoreactive α-Gal antigenic epitope by phage display. Biochemical and Biophysical Research Communications. 344(1). 214–220. 22 indexed citations
13.
Zhan, Jinbiao, et al.. (2004). A trans-Golgi network retention signal YQRL fused to ricin A chain significantly enhances its cytotoxicity. Biochemical and Biophysical Research Communications. 313(4). 1053–1057. 5 indexed citations
14.
Yan, Chunlan, et al.. (2004). [Polymorphic analysis of DYS287 and DYS440 in She ethnic in Zhejiang province China].. PubMed. 21(4). 410–1. 1 indexed citations
15.
Zhan, Jinbiao, et al.. (2003). A simplified method to evaluate the acute toxicity of ricin and ricinus agglutinin. Toxicology. 186(1-2). 119–123. 34 indexed citations
16.
Zhan, Jinbiao, et al.. (2003). A peptide mimetic of Gal-α1,3-Gal is able to block human natural antibodies. Biochemical and Biophysical Research Communications. 308(1). 19–22. 8 indexed citations
17.
Zhan, Jinbiao, et al.. (2003). Expression of ricin A chain and ricin A chain-KDEL in Escherichia coli. Protein Expression and Purification. 34(2). 197–201. 7 indexed citations
18.
Zhan, Jinbiao, et al.. (2003). A fusion protein of conotoxin MVIIA and thioredoxin expressed in Escherichia coli has significant analgesic activity. Biochemical and Biophysical Research Communications. 311(2). 495–500. 26 indexed citations
19.
Zhan, Jinbiao, Patrick S. Stayton, & Oliver W. Press. (1998). Modification of ricin A chain, by addition of endoplasmic reticulum (KDEL) or Golgi (YQRL) retention sequences, enhances its cytotoxicity and translocation. Cancer Immunology Immunotherapy. 46(1). 55–60. 16 indexed citations
20.
Zhan, Jinbiao, Maria de Sousa, John A. Chaddock, Lynne M. Roberts, & Janet M. Lord. (1997). Restoration of lectin activity to a non‐glycosylated ricin B chain mutant by the introduction of a novel N‐glycosylation site. FEBS Letters. 407(3). 271–274. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aizhi Zhao Breakdown of academic impact, for papers by Lai Sum Leoh Breakdown of academic impact, for papers by Mylène A. Carrascal Breakdown of academic impact, for papers by Sangeeta Bafna Breakdown of academic impact, for papers by Uli Binder Breakdown of academic impact, for papers by Ida H. van der Meulen‐Muileman Breakdown of academic impact, for papers by Debra L. Wood Breakdown of academic impact, for papers by Salam Kadhim Breakdown of academic impact, for papers by Hyunbo Shim
Rankless by CCL
2026